The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile ...

The Trump administration aims to change the Medicare Drug Price Negotiation Program in a way that would delay when certain ...

About a third of small businesses discontinue their health insurance coverage from one year to the next, new research from ...

In a new report, the Peterson Center on Healthcare made policy recommendations on reimbursement, access and data collection ...

The FDA laid out a three-year roadmap to phase out animal toxicity testing in drug research. In addition to organoids and lab ...

The Trump administration is not finalizing a Biden-era provision that would expand coverage of anti-obesity drugs under ...

The digital health funding market has been way up and way down over the past five years. As this roller coaster starts to settle down, one thing is clear to Randy Bolyga: that the industry is ...

The next wave of metabolic medicines in development includes oral GLP-1 drugs that work comparably to currently available injectable medicines, and Eli Lilly is taking the lead with Phase 3 ...

The scent of eucalyptus oil wafts through more households than ever. Herbal teas promising immunity boosts line mainstream grocery store shelves. Social media teems with influencers touting the ...

What if type 2 diabetes could nearly be eliminated? This isn’t even a thought experiment; it’s increasingly becoming a reality. A recent study found that Tirzepatide lowered the risk of ...

With rising operational costs, major shifts in Medicaid, and other financial pressures bearing down on the healthcare system, forecasting revenue and allocating resources effectively has never ...